2024-05-17 | Sale | Neurocrine Biosciences, Inc. NBIX | director | | $141.84 | $297,860 | -10.03% | |
2024-03-13 | Sale | Neurocrine Biosciences, Inc. NBIX | director | | $140.33 | $3.26M | -5.04% | |
2024-03-11 | Sale | Neurocrine Biosciences, Inc. NBIX | director | | $140.00 | $14,000 | -2.72% | |
2024-03-08 | Sale | Neurocrine Biosciences, Inc. NBIX | director | | $140.05 | $238,078 | -3.02% | |
2024-02-20 | Sale | Neurocrine Biosciences, Inc. NBIX | director | | $132.47 | $1.99M | +1.51% | |
2023-01-03 | Sale | Neurocrine Biosciences, Inc. NBIX | director | | $119.20 | $1.79M | -12.88% | |
2022-05-09 | Sale | Neurocrine Biosciences, Inc. NBIX | | | $76.30 | $572,252 | +36.98% | |
2022-05-05 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $27.85 | $2.61M | -4.37% | |
2021-05-18 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $20.00 | $6M | +15.63% | |
2021-05-11 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $22.09 | $6.63M | +12.58% | |
2021-05-06 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $19.95 | $3.99M | +13.95% | |
2020-05-14 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $13.37 | $2.01M | +27.67% | |
2020-05-07 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $13.18 | $1.32M | +28.29% | |
2020-04-02 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $12.77 | $1.28M | +31.03% | |
2020-03-26 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $13.05 | $1.96M | +26.89% | |
2020-03-19 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $14.47 | $2.17M | +27.42% | |
2019-11-14 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $14.36 | $2.87M | -11.64% | |
2019-11-08 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $19.73 | $1.19M | -12.31% | |
2019-11-07 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $14.51 | $2.03M | -10.41% | |
2019-09-19 | Sale | Alkermes plc ALKS | Director and CEO, Alkermes plc | | $15.37 | $3.07M | -12.56% | |